Nano-X Imaging Ltd.

NASDAQ:NNOX

Medical - Devices

Healthcare
$0.73 -1.45%

-$0.03 today

Market cap
$50.94M
Beta
1.17
P/E (TTM)
-1.5
EPS (TTM)
-$1.12
52W Low $1.59High $5.69

Volume 0.52M

Average 1.46M

NNOX Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Nano-X Imaging Ltd.NASDAQ: NNOX

Net Margin · Q4 FY2025 · quarter ended Dec 2025

Net margin narrows to -897.4%

Net margin was -897.4% in Q4 FY2025, down 428.7 pp from a year earlier. On a trailing-twelve-month basis it was -576.1%, down 101.8 pp year over year. Over 3 fiscal years it widened by 650.8 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 1 analysts of -412.0% for the fiscal year ending Dec 2026, up from -576.1% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterDec 2025
-897.4%-500.4 pp QoQ
Last fiscal yearDec 2025
-576.1%-101.8 pp YoY
LTMDec 2025
-576.1%-101.8 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-428.7 pp+162.1 pp+590.8 pp
1 year-101.8 pp+164.1 pp+265.9 pp
3 years+650.8 pp+540.1 pp-110.7 pp
5 years+566.0 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-576.1%
Year-over-year change
-101.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How NNOX compares with its peers on the latest reported figures

  • NNOX's LTM Dec 2025 net margin of -576.1% is the 9th highest of the 11 companies compared; the peer median is -79.8%.
  • Its year-over-year change of -101.8 pp is the 10th highest of 11, against a peer median of +12.0 pp.
  • Over three fiscal years its change of +650.8 pp compares with a peer median of +45.0 pp.
NNOX Competitors Peer median
Net Margin for NNOX and competitors
Company Period LTM level YoY 3-year change
SNWVSANUWAVE Health, Inc.LTM Mar 202636.2% +126.1 pp+88.3 pp
INGNInogen, Inc.LTM Mar 2026-7.1% +1.0 pp+15.7 pp
TLSITriSalus Life Sciences, Inc.LTM Mar 2026-60.9% +23.8 pp+293.7 pp
OMOutset Medical, Inc.LTM Mar 2026-63.7% +35.1 pp+72.9 pp
QTRXQuanterix CorporationLTM Mar 2026-71.9% -36.2 pp+17.1 pp
HCATHealth Catalyst, Inc.LTM Mar 2026-87.7% -64.4 pp-7.5 pp
MXCTMaxCyte, Inc.LTM Mar 2026-121.2% -10.2 pp-81.9 pp
PROFProfound Medical Corp.LTM Mar 2026-207.7% +23.0 pp+164.7 pp
NNOXNano-X Imaging Ltd.LTM Dec 2025-576.1% -101.8 pp+650.8 pp
HSDTSolana CompanyLTM Mar 2026-1427.1% +1583.0 pp+1108.5 pp
CATXPerspective Therapeutics, Inc.LTM Mar 2026-17982.7% -12192.6 pp-11458.8 pp
Peer median (excluding NNOX) -79.8%+12.0 pp+45.0 pp

Competitors are the stored peer set for NNOX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.3M8.58M9.91M11.28M13.02M
Cost of Revenue2.82M15.46M16.5M21.89M25.81M
Gross Profit(1.51M)(6.88M)(6.59M)(10.61M)(12.79M)
Gross Margin-116.0%-80.2%-66.6%-94.0%-98.2%
Research & Development17.12M26.51M26.05M20.18M19.24M
Selling, General & Admin41.74M45.63M28.39M25.75M27.1M
Operating Expenses60.05M72.33M56M46.14M47.91M
Depreciation & Amortization2.29M11.51M11.81M11.73M11.7M
EBITDA(59.27M)(75.7M)(47.69M)(45.01M)(49M)
EBITDA Margin-4544.9%-882.4%-481.5%-398.9%-376.3%
Operating Income(61.56M)(109.71M)(62.59M)(56.75M)(60.7M)
Operating Margin-4720.7%-1279.0%-631.9%-502.9%-466.2%
Interest Income0789K1.65M2.87M1.42M
Interest Expense288K0000
Other Income / Expenses(288K)(14.67M)1.47M2.87M(16.11M)
Income Before Tax(61.85M)(108.92M)(61.12M)(53.87M)(76.81M)
Pre-Tax Margin-4742.8%-1269.8%-617.0%-477.5%-589.9%
Income Tax Expense(48K)(3.68M)(339K)(358K)(1.79M)
Net Income(61.8M)(105.24M)(60.78M)(53.52M)(75.02M)
Net Margin-4739.1%-1226.9%-613.6%-474.3%-576.1%
EPS (Basic)(1.28)(2.01)(1.08)(0.91)(1.16)
EPS (Diluted)(1.28)(2.01)(1.08)(0.91)(1.16)
Weighted Avg Shares48.22M52.24M56.37M58.62M64.79M
Weighted Avg Shares (Diluted)48.22M52.24M56.37M58.62M64.79M

Nano-X Imaging Ltd.

NASDAQ:NNOX

Intrinsic Alpha fair value

Locked

Current Price

$0.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.